April 2, 2024
Evogene and The Kitchen FoodTech Hub by Strauss Group established Finally Foods Ltd. – Revolutionizing protein production in plants for the food industry
March 19, 2024
Bayer AG and Lavie Bio continue for second year of biofungicides validation following successful lab and greenhouse testing
March 7, 2024
Evogene reports fourth quarter and full year 2023 financial results
December 19, 2023
Casterra appoints new CEO and expands team to drive growth and innovation
November 16, 2023
Evogene reports third quarter 2023 financial results
October 18, 2023
Evogene provides operational update amidst current security situation in Israel
September 27, 2023
Casterra delivers first shipment of castor seeds to Africa
August 17, 2023
Evogene reports second quarter 2023 financial results
July 25, 2023
Evogene’s ChemPass AI tech-engine is introduced with new breakthrough machine learning technology for target-protein discovery
July 17, 2023
Evogene announces pricing of US$8,500,000 registered direct offering
Lavie Bio announces licensing agreement for bio-fungicides with Corteva Agriscience - Corteva to receive exclusive rights to further develop and commercialize Lavie Bio’s lead product candidates for fruit rot and powdery mildew fungicide biologicals
July 7, 2023
Evogene's subsidiary Casterra: $11.3M sale of castor plant seeds may be the tip of the iceberg (Seeking Alpha)
July 4, 2023
Casterra announces additional $2.2 million of purchase orders to supply castor seeds for new African territories
May 24, 2023
Lavie Bio receives Canadian regulatory approval for its bio-inoculant seed treatment Thrivus, expanding global reach
May 18, 2023
Evogene reports first quarter 2023 financial results
May 9, 2023
Evogene's ag-seed division awarded prestigious €1.2M Horizon grant to develop oilseed crops with high CO2 assimilation and drought tolerance
March 9, 2023
Evogene reports fourth quarter and full year 2022 financial results
January 19, 2023
Casterra announces agreement with world leading energy company to cultivate its castor varieties at commercial scale
December 8, 2022
Evogene to receive $3.5 million payment related to patent portfolio under its existing seed traits collaboration with Bayer
November 18, 2022
Evogene reports third quarter 2022 financial results
October 12, 2022
Lavie Bio advances its novel bio-fungicide program and applies to the U.S. EPA for regulatory approval - LAV.311 is targeting fruit rots and powdery mildews fungal diseases
August 31, 2022
Evogene reports second quarter 2022 financial results
August 18, 2022
ICL and Lavie Bio enter strategic collaboration to develop novel bio-stimulant products
May 26, 2022
Evogene reports first quarter 2022 financial results
March 10, 2022
Evogene reports fourth quarter and full year 2021 financial results
December 14, 2021
Lavie Bio reports advancement in its bio-fungicide program for fruit rots
November 17, 2021
Evogene reports third quarter 2021 financial results
November 10, 2021
Evogene announces participation in the second research period of the CRISPR-IL Consortium - Israeli Innovation Authority to continue funding the on-going development of an end-to-end artificial intelligence system for genome-editing
November 3, 2021
Lavie Bio announces commercial launch of its first microbiome-based product for yield improvement under the name Result - Result inoculant initially introduced for spring wheat in North Dakota, following positive four-year field trials
September 29, 2021
Lavie Bio and United Agronomy announce signing of distribution agreement for Lavie Bio’s inoculant product - Commercialization targeted for 2022 for spring wheat initially
www.evogene.com
Copyright @ 1992-2024 SeedQuest - All rights reserved